Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cell Therapy With TILs: Training and Taming T Cells to Fight Cancer.

Frontiers in immunology - 1 Jan 2021

Kumar Amrendra, Watkins Reese, Vilgelm Anna E

Abstract excerpt

The rationale behind cancer immunotherapy is based on the unequivocal demonstration that the immune system plays an important role in limiting cancer initiation and progression. Adoptive cell therapy (ACT) is a form of cancer immunotherapy that utilizes a patient's own immune cells to find and eliminate tumor cells, however, donor immune cells can also be employed in some cases. Here, we focus on T lymphocyte...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Immunotherapy, Adoptive
Share to Lymphocytes, Tumor-Infiltrating
Share to Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Phenotype

Share to T-Lymphocytes

Share to Treatment Outcome

Share to Tumor Microenvironment

Source

Open in PubMed Open full text

Identifiers

PMID: 34140957
DOI: 10.3389/fimmu.2021.690499
PMCID: PMC8204054

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cell Therapy With TILs: Training and Taming T Cells to Fight Cancer.PMID 34140957Read ↗

Adoptive T-Cell Therapy for Cancer.Semantic proximity Read ↗

Novel strategies to improve efficacy of treatment with tumor-infiltrating lymphocytes (TILs) for patients with solid cancers.Semantic proximity Read ↗

Advances in cancer immunotherapy: historical perspectives, current developments, and future directionsSemantic proximity Read ↗

Cancer Immunotherapy: Whence and Whither.Semantic proximity Read ↗

CD4 <sup>+</sup> tumor-infiltrating lymphocytes secreting T cell-engagers induce regression of autologous patient-derived non-small cell lung cancer xenograftsSemantic proximity Read ↗

Adoptive cellular therapy of cancer: exploring innate and adaptive cellular crosstalk to improve anti-tumor efficacy.Semantic proximity Read ↗

Modeling ex vivo tumor-infiltrating lymphocyte expansion from established solid malignanciesSemantic proximity Read ↗

Emerging Cellular Therapies for CancerSemantic proximity Read ↗

Focusing on CD8+ T-cell phenotypes: improving solid tumor therapy.Semantic proximity Read ↗

Engineered T cells for anti-cancer therapySemantic proximity Read ↗

Long-term efficacy of adoptive cell therapy is determined by host CD8 <sup>+</sup> T cells and undermined by lymphodepleting preconditioningSemantic proximity Read ↗

Tumor-infiltrating lymphocyte therapy for melanoma: rationale and issues for further clinical development.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.